Abstract
The effect of intratracheal surfactant instillation on pulmonary function in rats withPneumocystis carinii pneumonia (PCP) was investigated. In those animals which developed PCP with severe respiratory failure after administration of cortisone acetate s. c. over 8–12 weeks, pulmonary function was improved by surfactant instillation. PaO2 values 30 min after surfactant instillation were significantly higher compared to pretreatment values and also compared to PaO2 values of rats 30 min after receiving saline (482.9 mmHg±44.7, 170.7 mmHg ±39.3 and 67.2 mmHg±17.4, respectively). Histological examination showed that alveoli of rats with PCP which received no exogenous surfactant are filled with foamy edema, whereas after exogenous surfactant alveoli are stabilized and well-aerated. These results indicate that exogenous surfactant may help patients with severe PCP to overcome an acute stage of respiratory distress.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
CDC Update (1984) Acquired immuno-deficiency syndrome (AIDS)-United States. MMWR 32:688–691
Walzer PD, Perl DP, Krogstad DJ, Rawson PG, Schultz MG (1974)Pneumocystis carinii pneumonia in the United States: epidemiologic, diagnostic, and clinical features. Ann Intern Med 80:83–93
Sheehan PM, Stokes DC, Yeh Y, Hughes WT (1986) Surfactant phospholipids and lavage phospholipase A2 in experimentalpneumocystis carinii pneumonia. Am Rev Respir Dis 134:526–531
Kernbaum, S. Masliah J, Alcindor LG, Bouton C, Chritol D (1983) Phospholipase activities of bronchoalveolar lavage fluid in rat pneomocystis carinii pneumonia. Br J Exp Pathol 64:75–80
Berggren P, Lachmann B, Curstedt T, Grossmann, G, Robertson B (1986) Gas exchange and lung morphology after surfactant replacement in experimental adult respiratory distress syndrome induced by repeated lung lavage. Acta Anaesthesiol Scand 30:321–328
Kobayashi T, Ganzuka M, Taniguchi J, Nitta K, Murakami S (1990) Lung lavage and surfactant replacement for hydrochloric acid aspiration in rabbits. Acta Anaesthesiol Scand 34:216–221
Fujiwara, T, Chida, S, Watabe Y, Maeta H, Morita T, Abe T (1980) Artificial surfactant therapy in hyaline-membrane disease. Lancet I:55–59
Hallman M, Merritt TA, Jarvenpaa A-L, Boynton B, Mannino F, Gluck L, Moore T, Edwards D (1985) Exogenous human surfactant for treatment of severe respiratory distress syndrome: a randomized clinical trial. J Pediatr 106:963–969
Collaborative European Multicenter Study Group (1988) Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Pediatrics 82:683–691
Ten Centre Study Group (1987) Ten centre trial of artificial surfactant (artificial lung expanding compound) in very premature babies. Br Med J 294:991–996
Metcalfe IL, Enhorning G, Possmayer F (1980) Pulmonary surfactant-associated proteins: their role in the expression of surface activity. J Appl Physiol 49:34–41
Frenkel JK, Good JT, Schultz JA (1966) Latent pneumocystis infection of rats, relapse, and chemotherapy. Lab Invest 15:1559–1577
Chandler FW, Frenkel JK, Campbell WG (1979) Animal model of human disease:pneumocystis pneumonia. Am J Pathol 95:571–574
Musto L, Flanigan M, Elbadawi A (1982) Ten-minute silver stain forpneumocystis carinii and fungi in tissue sections. Arch Pathol Lab Med 106:292–294
Clements JA (1977) Functions of the alveolar lining. Am Rev Respir Dis 115:67–71
Lachmann B (1988) Surfactant replacement in acute respiratory failure: animal studies and first clinical trials. In: Lachmann B (ed) Surfactant replacement therapy in neonatal and adult respiratory distress syndrome. Springer, Berlin, pp 212–223
Ikegami M, Jobe A, Jacobs H, Lam R (1984) A protein from airways of premature lambs that inhibits surfactant function. J Appl Physiol 57:1134–1142
Holm BA, Enhorning G, Notter RH (1988) A biophysical mechanism by which plasma proteins inhibit lung surfactant activity. Chem Phys Lipids 49:49–55
Seeger W, Stöhr G, Wolf HRD, Neuhof H (1985) Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer. J Appl Physiol 58:326–338
Guyton AC, Moffat DS, Adair TH (1984) Role of alveolar surface tension in trasepithelial movement of fluid. In: Robertson B, Van Golde LMG, Batenburg JJ (eds) Pulmonary surfactant. Elsevier, Amsterdam, pp 171–185
Beers MF, Sohn M, Swartz M (1990) Histological evidence of peripheral tissue destruction in AIDS patients withpneumocystis carinii pneumonia complicated by recurrent spontaneous pneumothorax. Am Rev Respir Dis 141 [Suppl]:A273
Yoneda K, Walzer PD (1981) Mechanism of pulmonary alveolar injury in experimentalpneumocystis carinii pneumonia in the rat. Br J Exp Pathol 62:339–346
Levine SJ, White DA (1988)Pneumocystis carinii. Clin Chest Med 9:395–423
Montgomery AB, Debs RJ, Luce JM, Corkery KJ, Turner J, Brunette EN, Lin ET, Hopewell PC (1987) Aerosolized pentamidine as sole therapy forpneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Lancet II:480–483
Debs RJ, Blumenfeld W, Brunette EN, Straubinger RM, Montgomery AB, Lin E, Agabian N, Papahadjopoulos D (1987) Successful treatment with aerosolized pentamidine ofpneumocystis carinii pneumonia in rats. Antimicrob Agents Chemother 31:37–41
Author information
Authors and Affiliations
Additional information
This work was financially supported, in part, by The Dutch Foundation for Medical Research (SFMO)
Rights and permissions
About this article
Cite this article
Eijking, E.P., van Daal, G.J., Tenbrinck, R. et al. Effect of surfactant replacement onPneumocystis carinii pneumonia in rats. Intensive Care Med 17, 475–478 (1991). https://doi.org/10.1007/BF01690770
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01690770